Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in CRDF — Cardiff Oncology, Inc.

CIK 1000275 TORONTO, A6
Back to CRDF Full portfolio

Position in CRDF

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$16,017
+$7,590 QoQ
Shares Held
12,322
+136.9% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 104 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRDF Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. CRDF ranks #246 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in CRDF

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,017 12,322
2026-03-31 $8,427 5,202
2025-12-31 $4,845 1,725
2025-09-30 $239,794 116,406
2025-06-30 $603,369 191,546
2025-03-31 $130,635 41,604
2024-12-31 $285,945 65,886
2024-09-30 $14,329 5,367
2024-06-30 $46,774 21,070
2024-03-31 $80,100 15,000
2023-12-31 $689 466
2023-09-30 $405 292
2023-06-30 $28,367 19,299
2023-03-31 $31,320 18,982
2022-12-31 $32,174 22,982
2022-09-30 $41,344 26,848
2022-06-30 $59,104 26,866
2022-03-31 $82,675 33,337
2021-12-31 $294,921 49,072
2021-09-30 $217,328 32,632
2021-06-30 $90,938 13,675
2021-03-31 $131,492 14,200
2020-12-31 $164,050 9,119
2020-09-30 $28,380 2,000